Home
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

82 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Completed

Steroids and Methotrexate to Treat Systemic Vasculitis

NCT00001256

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +23 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Etanercept to Treat Wegener's Granulomatosis

NCT00001901

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis

NCT00001541

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +15 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

NCT00001473

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Daclizumab to Treat Wegener's Granulomatosis

NCT00040248

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

NCT00072592

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

NCT00001759

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

NCT00001761

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +15 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Diagnostic Effectiveness of Virtual Bronchoscopy

NCT00001515

Conditions: Actinomycetales Infections, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +44 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Related conditions